Patents by Inventor Lalit Kumar Baregama

Lalit Kumar Baregama has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pyrazolo (3, 4-B) pyridine derivatives as phosphodiesterase inhibitors
    Patent number: 8420666
    Abstract: The present invention relates to phosphodiesterase (PDE) type 4, phosphodiesterase (PDE) type 7 and dual PDE type 4/PDE type 7 inhibitors.
    Type: Grant
    Filed: March 14, 2008
    Date of Patent: April 16, 2013
    Assignee: Ranbaxy Laboratories Limited
    Inventors: Sonali Rudra, Nidhi Gupta, Lalit Kumar Baregama, Ritu Agarwal, Vinayak Vasantrao Khairnar, Mandadapu Raghu Ramaiah, Venkata P. Palle, Sarala Balachandran, Atul Kondaskar, Manohar Salla, Abhijit Ray, Sunanda G. Dastidar, Lalitha Vijaykrishnan
  • PYRAZOLO [3, 4-B] PYRIDINE DERIVATIVES AS PHOSPHODIESTERASE INHIBITORS
    Publication number: 20110130403
    Abstract: The present invention relates to phosphodiesterase (PDE) type 4, phosphodiesterase (PDE) type 7 and dual PDE type 4/PDE type 7 inhibitors.
    Type: Application
    Filed: March 13, 2008
    Publication date: June 2, 2011
    Applicant: RANBAXY LABORATORIES LIMITED
    Inventors: Sonali Rudra, Nidhi Gupta, Lalit Kumar Baregama, Ritu Agarwal, Mandadapu Raghuramaiah, Vinayak Vasantrao Khairnar, Venkata P. Palle, Sarala Balachandran, Abhijit Ray, Sunada G. Dastidar, Lalitha Vijaykrishnan
  • INHIBITORS OF PHOSPHODIESTERASE TYPE-IV
    Publication number: 20110021473
    Abstract: The present invention relates to catechol derivatives of formula (I), which can be used as inhibitors of phosphodiesterase (PDPI) type 4 or type 7, Compounds disclosed herein can be useful in the treatment of CNS disorders, inflammatory diseases such as, AIDS, asthma, arthritis, bronchitis, chronic obstructive pulmonary disease (COPD), psoriasis, allergic rhinitis, shock, atopic dermatitis, Crohn's disease, adult respiratory distress syndrome (ARDS), eosinophilic granuloma, allergic conjunctivitis, osteoarthritis, ulcerative colitis and other inflammatory diseases especially in humans. Processes for the preparation of disclosed compounds are provided, as well as pharmaceutical compositions containing the disclosed compounds, and their use as phosphodiesterase (PDE) type 4 or type 7 inhibitors.
    Type: Application
    Filed: September 22, 2007
    Publication date: January 27, 2011
    Inventors: Sonali Rudra, Nidhi Gupta, Lalit Kumar Baregama, Ritu Agarwal, Vinayak Vasantrao Khairnar, Saswati Chakladar, Mandadapu Raghu Ramaiah, Nagarajan Muthukamal, Sarala Balachandran, Sarika Ramnani, Venkata P. Palle, Sunanda G. Dastidar, Abhijit Ray, Lalitha Vijaykrishan, Jitendra Sattigeri
  • PYRAZOLO (3, 4-B) PYRIDINE DERIVATIVES AS PHOSPHODIESTERASE INHIBITORS
    Publication number: 20100292196
    Abstract: The present invention relates to phosphodiesterase (PDE) type 4, phosphodiesterase (PDE) type 7 and dual PDE type 4/PDE type 7 inhibitors.
    Type: Application
    Filed: March 14, 2008
    Publication date: November 18, 2010
    Applicant: RANBAXY LABORATORIES LIMITED
    Inventors: Sonali Rudra, Nidhi Gupta, Lalit Kumar Baregama, Ritu Agarwal, Vinayak Vasantrao Khairnar, Mandadapu Raghu Ramaiah, Venkata P. Palle, Sarala Balachandran, Atul Kondaskar, Manohar Salla, Abhijit Ray, Sunanda G. Dastidar, Lalitha Vijaykrishnan
  • Substituted indazoles as inhibitors of phosphodiesterase type-IV
    Patent number: 7781460
    Abstract: The present invention relates to isoxazoline derivatives of structure Ia, which can be used as selective inhibitors of phosphodiesterase (PDE) type IV. Compounds disclosed herein can be useful in the treatment of CNS disorders, AIDS, asthma, arthritis, bronchitis, chronic obstructive pulmonary disease (COPD), psoriasis, allergic rhinitis, shock, atopic dermatitis, Crohn's disease, adult respiratory distress syndrome (ARDS), eosinophilic granuloma, allergic conjunctivitis, osteoarthritis, ulcerative colitis and other inflammatory diseases especially in humans. Processes for the preparation of disclosed compounds are provided, as well as pharmaceutical compositions containing the disclosed compounds, and their use as phosphodiesterase (PDE) type IV inhibitors.
    Type: Grant
    Filed: August 30, 2006
    Date of Patent: August 24, 2010
    Assignee: Ranbaxy Laboratories Limited
    Inventors: Venkata Palle, Sarala Balachandran, Lalit Kumar Baregama, Saswati Chakladar, Sarika Ramnani, Nagarajan Muthukamal, Abhijit Ray, Sunanda G. Dastidar
  • Substituted Indazoles as Inhibitors of Phosphodiesterase Type-Iv
    Publication number: 20080312285
    Abstract: The present invention relates to isoxazoline derivatives of structure Ia, which can be used as selective inhibitors of phosphodiesterase (PDE) type IV. Compounds disclosed herein can be useful in the treatment of CNS disorders, AIDS, asthma, arthritis, bronchitis, chronic obstructive pulmonary disease (COPD), psoriasis, allergic rhinitis, shock, atopic dermatitis, Crohn's disease, adult respiratory distress syndrome (ARDS), eosinophilic granuloma, allergic conjunctivitis, osteoarthritis, ulcerative colitis and other inflammatory diseases especially in humans. Processes for the preparation of disclosed compounds are provided, as well as pharmaceutical compositions containing the disclosed compounds, and their use as phosphodiesterase (PDE) type IV inhibitors.
    Type: Application
    Filed: August 30, 2006
    Publication date: December 18, 2008
    Inventors: Venkata Palle, Sarala Balachandran, Lalit Kumar Baregama, Saswati Chakladar, Sarika Ramnani, Nagarajan Muthukamal, Abhijit Ray, Sunanda G. Dastidar
  • Phosphodiesterase Inhibitors
    Publication number: 20080280926
    Abstract: The present invention relates to purine derivatives, which can be used as selective phosphodiesterase (PDE) type IV inhibitors. Compounds disclosed herein can be useful in the treatment of asthma, arthritis, bronchitis, chronic obstructive pulmonary disease (COPD), psoriasis, allergic rhinitis, shock, atopic dermatitis, Crohn's disease, adult respiratory distress syndrome (ARDS), eosinophilic granuloma, allergic conjunctivitis, osteoarthritis, ulcerative colitis and other inflammatory diseases especially in humans. Also provided are processes for the preparation of disclosed compounds, pharmaceutical composition containing the disclosed compounds and their use as selective phosphodiesterase (PDE) type IV inhibitors.
    Type: Application
    Filed: December 16, 2004
    Publication date: November 13, 2008
    Inventors: Venkata P. Palle, Sarala Balachandran, Mohammad Salman, Gagan Kukreja, Lalit Kumar Baregama, Abhijit Ray, Sunanda Ghosh Dastidar